Free preview. Sign up free to see the team, full portfolio, ownership chain, and shareholding history.
Sign up freePricing

Invus Public Equities, L.P. investment portfolio

Invus Public Equities, L.P. has made numerous investments in companies such as Artios Pharma, Evox Therapeutics, and Ottimo Pharma within the Healthcare & Life Sciences sector.

unknown
Portfolio
3
Team
0

Portfolio (3)

CompanySectorCitySourceLast confirmed on
Artios Pharma Limited
Artios Pharma Limited develops DNA‑damage‑response‑based cancer therapeutics. Its pipeline includes the ATR inhibitor alnodesertib and the Polθ inhibitor ART6043, targeting hard‑to‑treat solid tumours.
Healthcare & Life SciencesCambridgeConfirmed2025-12-28
Evox Therapeutics Limited
Evox Therapeutics develops exosome‑based gene‑editing medicines that use a proprietary CRISPR editor delivered via extracellular vesicles to create safer, scalable treatments for severe neurodegenerative diseases, targeting patients with brain‑related genetic disorders.
Healthcare & Life SciencesOxfordConfirmed2026-03-16

Sign up to see the full portfolio

+1 more company

Sign up

Shareholding changes (3)

Invus Public Equities, L.P.'s positions across portfolio companies
2025

Sign up free to see when this investor has bought or sold shares.

+1 more change

Sign up